Monday, Nov 6, 2023 | 1:00 PM ET

The Real ROI of GLP-1s: A deep dive into third party-validated ROI models for approaching weight health care coverage at an organization

The Real ROI of GLP-1s: A deep dive into third party-validated ROI models for approaching weight health care coverage at an organization

Employers are facing two very distinct approaches to addressing the full spectrum of weight health within their population: the “offensive” approach which usually tends to cover anti-obesity medications like GLP-1s, and the “defensive” approach which leans more conservatively in benefit coverage or addressing new weight treatments. These two strategies have their own risks and rewards—and most importantly, both have significant short-term and long-term effects on an organization’s healthcare costs and potential ROI.


Join us as we explore the only third party-validated ROI models for the employer market from the Santa Barbara Actuaries firm and what this means for organizations looking to expand or retract weight health care coverage for their population.

WATCH LIVE IN

MODERATOR

Eva VyasHead of Healthcare Market Access, WeightWatchers

PANELISTS

Rich GamretManaging Director and Consulting Actuary, Santa Barbara Actuaries

Dr. Amy MeisterChief Medical Officer, WeightWatchers

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved